Nevro Corp. (NVRO) |
| 5.84 0 (0%) 04-02 16:00 |
| Open: | 5.84 |
| High: | 5.86 |
| Low: | 5.84 |
| Volume: | 751,504 |
| Market Cap: | 224(M) |
| PE Ratio: | -1.91 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 13.3 |
| 52w Low: | 3.165 |
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Thu, 03 Apr 2025
Nevro Corp Completes Merger and Delists from NYSE - TipRanks
Thu, 03 Apr 2025
Nevro Corp completes merger with Globus Medical - Investing.com
Tue, 04 Mar 2025
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results - PR Newswire
Tue, 11 Feb 2025
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain? - Yahoo Finance
Thu, 06 Feb 2025
Globus Medical to buy California life sciences firm for $250M - The Business Journals
Thu, 06 Feb 2025
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - GlobeNewswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |